Avience Biomedicals Ltd IPO
SMEPrice Band
₹196-208
Issue Size
₹30.24 Cr
Lot Size
1200
Open Date
18 Jun 2026
Close Date
22 Jun 2026
Listing Date
25 Jun 2026
This IPO is Closed
Avience Biomedicals Ltd IPO Timeline
Track key IPO dates — from opening and closing to allotment, refund, and listing.
IPO Open Date
18 Jun 2026
IPO Close Date
22 Jun 2026
Allotment Date
23 Jun 2026
Refund Date
24 Jun 2026
Credit to Demat
24 Jun 2026
Listing Date
25 Jun 2026
Avience Biomedicals Ltd IPO Subscription Status
See how the issue is being subscribed across QIB, NII, Retail, and Employee categories.
| Date | QIB | NII | RII | Employee | Total |
|---|---|---|---|---|---|
| 18 Jun 2026 | 0.00x | 9.61x | 15.23x | 0.00x | 9.68x |
| 19 Jun 2026 | 0.03x | 47.70x | 58.02x | 0.00x | 39.96x |
| 22 Jun 2026 | 196.77x | 427.77x | 401.36x | 0.00x | 355.06x |
Avience Biomedicals Ltd IPO Financials
A quick look at revenue, EBITDA, profit, and net worth over the last three years.
| Year | Total Revenue (Cr) | EBITDA (Cr) | PAT (Cr) | Networth (Cr) | EPS (₹) |
|---|---|---|---|---|---|
| FY26-03 | 35.50 | 11.09 | 6.73 | 27.14 | 16.70 |
| FY25-03 | 29.54 | 8.22 | 5.00 | 20.41 | 13.19 |
| FY24-03 | 16.64 | 3.61 | 2.00 | 6.07 | 6.09 |
Avience Biomedicals Ltd IPO Strengths
- Experienced Management Team and trained Employees.
- Optimal Utilization of Resources.
- Quality assurance and control.
- Cordial relationships with our clients.
Avience Biomedicals Ltd IPO Reservation
See what share of the issue is reserved for Retail, QIB, NII, and Anchor investors.
| Category | Shares Offered | % of Total |
|---|---|---|
| Retail | 4,81,200 | 33.1% |
| QIB | 2,73,600 | 18.82% |
| NII / HNI | 2,07,000 | 14.24% |
| Anchor Investors | 4,09,800 | 28.19% |
| Market Makers | 82,200 | 5.65% |
| Total | 14,53,800 | 100% |
Avience Biomedicals Ltd Registrar & Company Details
Registrar
Skyline Financial Services Pvt
D-153/A 1st Flr, Okhla Industrial Are, Phase-I, New Delhi-110020
011-40450193-197
ipo@skylinerta.com
www.skylinerta.com
Company
Avience Biomedicals Ltd
C-11 Block-C Community Cemtre, Janakpuri A-3, Delhi, 110058
1800-12-04-636
info@avienbio.com
CIN: U74999DL2019PLC359158
http://www.avienbio.com
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
The Avience Biomedicals Ltd IPO has an issue size of ₹30.24 crore.
The minimum investment required for the Avience Biomedicals Ltd IPO is ₹2,49,600, based on a minimum lot size of 1200 shares and the applicable IPO price.
The lot size for the Avience Biomedicals Ltd IPO is 1200 shares.
The allotment for the Avience Biomedicals Ltd IPO is scheduled for 23 Jun 2026.
Investors can check the Avience Biomedicals Ltd IPO allotment status using their PAN, application number, or other required details through the IPO registrar's website or the relevant stock exchange website.
The registrar for the Avience Biomedicals Ltd IPO is Skyline Financial Services Pvt.
The Avience Biomedicals Ltd IPO opens on 18 Jun 2026 and closes on 22 Jun 2026.
You can apply for the IPO through Anand Rathi using the applicable IPO application process:
Note: Investors are requested to do their own due diligence before investing in any IPO.
The Avience Biomedicals Ltd IPO is scheduled to be listed on 25 Jun 2026 on NSE - SME.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
